Assessing the long-term implications of age 9 initiation of HPV vaccination on series completion by age 13–15 in the US: projections from an age-structured vaccination model
Kunal Saxena,
Oscar Patterson-Lomba,
Andres Gomez-Lievano
et al.
Abstract:IntroductionRoutine human papillomavirus (HPV) vaccination in the US is recommended at ages 11 or 12 years and can be given at age 9. Vaccination completion rates among adolescents 13–15 years in the US remain below the 80% goal. This study evaluated the long-term effects of increasing proactive HPV vaccination initiation rates at age 9 years in completion rates of adolescents.MethodsAn age-structured vaccination model was developed and parametrized based on the National Immunization Survey-Teen (NIS-Teen) sur… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.